SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Evelo Biosciences, Inc. (EVLO) .
本页证实的标准:
- VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。
SharesGrow 综合评分： 28/100 其中 0/7 项标准通过。
SharesGrow 7-Criteria Score
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
估值概览 — EVLO
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$-26.28
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2016 |
$-94.06 |
$0.00 |
$-13.33M |
- |
| 2017 |
$-149.55 |
$0.00 |
$-28.05M |
- |
| 2018 |
$-49.25 |
$0.00 |
$-53.85M |
- |
| 2019 |
$-53.49 |
$0.00 |
$-85.66M |
- |
| 2020 |
$-47.45 |
$0.00 |
$-93.67M |
- |
| 2021 |
$-46.18 |
$0.00 |
$-122.18M |
- |
| 2022 |
$-26.28 |
$0.00 |
$-114.53M |
- |
